The AAPP Outcomes Initiative grant was awarded during AAPP 2024. In 2023, AAPP committed up to $500,000 to directly support multi-site research related to the impact of psychiatric pharmacists on patient care through the AAPP Foundation. In September of 2023, 6 pre-applications were received and evaluated by the taskforce. After multiple points of feedback, 2 finalists submitted their applications on April 1, 2024.
A panel of 8 researchers evaluated both applications and eventually awarded $247,352 to the winning project:
Psychiatric pharmacist management of cardiometabolic risk for adults with serious mental illness in outpatient safety-net mental health clinics in San Francisco
The primary investigator and co-investigators are Esti Iturralde, PhD, Anne Rosenthal, MD, and Hannah Van Ochten, PharmD of Kaiser Permanente Northern California Division of Research.
AAPP is working hard to standardize and improve clinical research through various initiatives, and the awarding of this grant represents a significant milestone in the multi-phase initiative. The mission of the American Association of Psychiatric Pharmacists (AAPP) is to advance the reach and practice of psychiatric pharmacy and serve as the voice of the specialty. High quality research that supports the integration of psychiatric pharmacists into mental health care teams is critical for the advancement of the profession. The primary goal of this funded research is to generate high-quality large sample size (n) data sets that evaluate the impact of integrating psychiatric pharmacists into team-based mental health care in studies with multiple research sites and investigators.
